ATE549340T1 - Spiroindolinon-derivate als mdm2-p53 inhibitoren - Google Patents

Spiroindolinon-derivate als mdm2-p53 inhibitoren

Info

Publication number
ATE549340T1
ATE549340T1 AT08759539T AT08759539T ATE549340T1 AT E549340 T1 ATE549340 T1 AT E549340T1 AT 08759539 T AT08759539 T AT 08759539T AT 08759539 T AT08759539 T AT 08759539T AT E549340 T1 ATE549340 T1 AT E549340T1
Authority
AT
Austria
Prior art keywords
mdm2
inhibitors
spiroindolinone derivatives
spiroindolinone
derivatives
Prior art date
Application number
AT08759539T
Other languages
English (en)
Inventor
Jin-Jun Liu
Zhuming Zhang
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE549340T1 publication Critical patent/ATE549340T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT08759539T 2007-05-23 2008-05-13 Spiroindolinon-derivate als mdm2-p53 inhibitoren ATE549340T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93136807P 2007-05-23 2007-05-23
PCT/EP2008/055831 WO2008141975A1 (en) 2007-05-23 2008-05-13 Spiroindolinone derivatives

Publications (1)

Publication Number Publication Date
ATE549340T1 true ATE549340T1 (de) 2012-03-15

Family

ID=39645560

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08759539T ATE549340T1 (de) 2007-05-23 2008-05-13 Spiroindolinon-derivate als mdm2-p53 inhibitoren

Country Status (16)

Country Link
US (1) US7834179B2 (de)
EP (1) EP2152714B1 (de)
JP (1) JP2010527954A (de)
KR (1) KR20090130319A (de)
CN (1) CN101679448A (de)
AR (1) AR066659A1 (de)
AT (1) ATE549340T1 (de)
AU (1) AU2008253117A1 (de)
BR (1) BRPI0812155A2 (de)
CA (1) CA2687160A1 (de)
ES (1) ES2382139T3 (de)
IL (1) IL202020A0 (de)
MX (1) MX2009012595A (de)
PE (1) PE20090718A1 (de)
TW (1) TW200901994A (de)
WO (1) WO2008141975A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776875B2 (en) * 2007-12-19 2010-08-17 Hoffman-La Roche Inc. Spiroindolinone derivatives
US7723372B2 (en) 2008-03-19 2010-05-25 Hoffman-La Roche Inc. Spiroindolinone derivatives
US8217051B2 (en) * 2009-02-17 2012-07-10 Hoffmann-La Roche Inc. Spiroindolinone derivatives
UA107814C2 (uk) * 2009-11-12 2015-02-25 Дзе Ріджентс Оф Дзе Юніверсіті Оф Мічіган Спірооксіндольні антагоністи мdм2
JO2998B1 (ar) 2010-06-04 2016-09-05 Amgen Inc مشتقات بيبيريدينون كمثبطات mdm2 لعلاج السرطان
FR2967072B1 (fr) 2010-11-05 2013-03-29 Univ Dundee Procede pour ameliorer la production de virus et semences vaccinales influenza
JP2014500870A (ja) 2010-11-12 2014-01-16 ザ、リージェンツ、オブ、ザ、ユニバーシティ、オブ、ミシガン スピロ−オキシインドールｍｄｍ２アンタゴニスト
SG193002A1 (en) 2011-03-10 2013-09-30 Daiichi Sankyo Co Ltd Dispiropyrrolidine derivative
WO2012155066A2 (en) 2011-05-11 2012-11-15 Shaomeng Wang Spiro-oxindole mdm2 antagonists
US9376425B2 (en) 2011-09-27 2016-06-28 Amgen, Inc. Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
TWI586668B (zh) 2012-09-06 2017-06-11 第一三共股份有限公司 二螺吡咯啶衍生物之結晶
WO2014089904A1 (en) 2012-12-10 2014-06-19 Abbvie Inc. Triazinone compounds
KR102196882B1 (ko) 2012-12-20 2020-12-30 머크 샤프 앤드 돔 코포레이션 Hdm2 억제제로서의 치환된 이미다조피리딘
US11407721B2 (en) 2013-02-19 2022-08-09 Amgen Inc. CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer
WO2014134201A1 (en) 2013-02-28 2014-09-04 Amgen Inc. A benzoic acid derivative mdm2 inhibitor for the treatment of cancer
MX374513B (es) 2013-03-14 2025-03-06 Amgen Inc Compuestos de morfolinona de ácido heteroarilo como inhibidores mdm2 para el tratamiento de cáncer.
CN105358530A (zh) 2013-06-10 2016-02-24 美国安进公司 制备mdm2抑制剂的方法及其结晶形式
CN103435621B (zh) * 2013-07-26 2015-11-04 中国林业科学研究院林产化学工业研究所 螺环喹唑啉衍生物及其制备方法
WO2016001376A1 (en) 2014-07-03 2016-01-07 Boehringer Ingelheim International Gmbh New spiro[3h-indole-3,2´-pyrrolidin]-2(1h)-one compounds and derivatives as mdm2-p53 inhibitors
RS59111B1 (sr) 2014-08-21 2019-09-30 Boehringer Ingelheim Int Nova jedinjenja spiro[3h-indol-3,2´-pirolidin]-2(1h)-ona i derivati kao mdm2-p53 inhibitori
CA2976752C (en) 2015-02-20 2019-12-17 Daiichi Sankyo Company, Limited Method for treating cancer by combined use
JP6823587B2 (ja) 2015-04-13 2021-02-03 第一三共株式会社 Ｍｄｍ２阻害剤とｂｔｋ阻害剤との併用治療法
KR20240158360A (ko) 2015-10-09 2024-11-04 베링거 인겔하임 인터내셔날 게엠베하 Mdm2-p53 억제제로서의 스피로[3h-인돌-3,2'-피롤리딘]-2(1h)-온 화합물 및 유도체
CN118436801A (zh) 2016-05-20 2024-08-06 豪夫迈·罗氏有限公司 Protac抗体缀合物及其使用方法
EP3527226A4 (de) 2016-10-17 2020-06-17 Daiichi Sankyo Company, Limited Kombinationstherapieverfahren mit mdm2-inhibitor und dna-methyltransferase-inhibitor
EP3511334A1 (de) * 2018-01-16 2019-07-17 Adamed sp. z o.o. 1,2,3',5'-tetrahydro-2'h-spiro[indol-3,1'-pyrrolo[3,4-c]pyrrol] -2,3'-dion-verbindungen als therapeutische mittel, die tp53 aktivieren
WO2023056069A1 (en) 2021-09-30 2023-04-06 Angiex, Inc. Degrader-antibody conjugates and methods of using same
WO2024240858A1 (en) 2023-05-23 2024-11-28 Valerio Therapeutics Protac molecules directed against dna damage repair system and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100944301B1 (ko) * 2005-02-22 2010-02-24 더 리젠츠 오브 더 유니버시티 오브 미시간 Ｍｄｍ２의 소분자 억제제 및 이의 용도
CA2617042A1 (en) * 2005-07-29 2007-02-01 Takeda Pharmaceutical Company Limited Spiro-cyclic compound

Also Published As

Publication number Publication date
IL202020A0 (en) 2010-06-16
MX2009012595A (es) 2009-12-07
TW200901994A (en) 2009-01-16
BRPI0812155A2 (pt) 2019-09-24
EP2152714A1 (de) 2010-02-17
US7834179B2 (en) 2010-11-16
CA2687160A1 (en) 2008-11-27
WO2008141975A1 (en) 2008-11-27
AU2008253117A1 (en) 2008-11-27
PE20090718A1 (es) 2009-06-20
ES2382139T3 (es) 2012-06-05
EP2152714B1 (de) 2012-03-14
JP2010527954A (ja) 2010-08-19
CN101679448A (zh) 2010-03-24
AR066659A1 (es) 2009-09-02
KR20090130319A (ko) 2009-12-22
US20080293723A1 (en) 2008-11-27

Similar Documents

Publication Publication Date Title
ATE549340T1 (de) Spiroindolinon-derivate als mdm2-p53 inhibitoren
CY2020023I1 (el) Αναστολεiς βητα-λακταμασων
LTPA2020528I1 (lt) Benzimidazolo dariniai
CY2017016I2 (el) Αναστολεις πρωτεασωματος
BRPI0810365A2 (pt) Inibidores de mlc-1 de indol 7-substituído
ATE510825T1 (de) Acylaminopyrazole als fgfr-inhibitoren
BRPI0814797A2 (pt) Inibidores dna-pk
DK2308877T3 (da) Imidazopyridin-2-on-derivater
ATE506358T1 (de) 2-benzylpyridazinonderivate als met-kinasehemmer
DK2164844T3 (da) Pyrimidinyl-pyridazinonderivater
BRPI0918846A2 (pt) inibidores de cinase heterocíclica
DK2209786T3 (da) Pyrimidinsubstituerede purinderivater
DK2041138T3 (da) Pyrroltriazinkinase-inhibitorer
DK2024375T3 (da) Cyclopropyl-kondenserede indolobenzazepin-HCV-NS5B-hæmmere
ATE546444T1 (de) Amidophenoxyindazole als c-met-hemmer
BRPI0813836A2 (pt) Derivados pirazólicos
DK2142533T3 (da) Imidazolidinonderivater
ATE467623T1 (de) Diazepan-acetamidderivate als selektive 11-hsd1- hemmer
BRPI0918564A2 (pt) inibidores
BRPI0915064A2 (pt) derivados de qunoxalinadiona
BRPI0906705A2 (pt) Composto heterocíclicos
ATE518837T1 (de) Indazolamidderivate
BRPI0913832A2 (pt) derivados de pirrolopiridinilpirimidin-2-ilamina
CR10879A (es) Cyclized derivatives as eg-5 inhibitors
DK2152370T3 (da) Aryletherpyridazinonderivater